SENS (Senseonics Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena

SENS (Senseonics Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena

SENSSenseonics Holdings, Inc.

Mkt Cap$254M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$35M

Net Income (TTM)-$69M

EPS (TTM)-$1.85

Free Cash Flow (TTM)-$65M

Gross Margin44.7%

Op. Margin-193.5%

Net Margin-196.0%

FCF Margin-184.7%

P/S Ratio (TTM)7.2x

P/E Ratio (TTM)—

YoY Rev Growth+56.9%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$4M	$414K	-$20M
Q2 23	$4M	$417K	-$20M
Q3 23	$6M	$1M	-$19M
Q4 23	$8M	$1M	-$17M
Q1 24	$5M	$335K	-$18M
Q2 24	$5M	$298K	-$19M
Q3 24	$4M	-$4M	-$23M
Q4 24	$8M	$4M	-$14M
Q1 25	$6M	$2M	-$13M
Q2 25	$8M	$4M	-$14M
Q3 25	$8M	$3M	-$20M
Q4 25	$13M	$7M	-$21M

Valuation

Quarter	P/S	P/E
Q1 23	14.1x	4.5x
Q2 23	13.8x	—
Q3 23	12.8x	—
Q4 23	11.4x	—
Q1 24	10.9x	—
Q2 24	10.6x	—
Q3 24	11.4x	—
Q4 24	11.3x	—
Q1 25	10.7x	—
Q2 25	9.4x	—
Q3 25	8.2x	—
Q4 25	7.2x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$20M	-$20M
Q2 23	-$18M	-$18M
Q3 23	-$17M	-$17M
Q4 23	-$15M	-$15M
Q1 24	-$20M	-$21M
Q2 24	-$11M	-$13M
Q3 24	-$15M	-$15M
Q4 24	-$14M	-$14M
Q1 25	-$16M	-$17M
Q2 25	-$9M	-$9M
Q3 25	-$16M	-$16M
Q4 25	-$23M	-$23M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$57K
Q2 23	$0
Q3 23	$123K
Q4 23	$170K
Q1 24	$316K
Q2 24	$2M
Q3 24	$203K
Q4 24	$34K
Q1 25	$434K
Q2 25	$124K
Q3 25	$164K
Q4 25	$304K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+66.7%	+35.2%
Q2 23	+11.1%	+15.6%
Q3 23	+31.9%	+13.2%
Q4 23	+44.1%	+2.5%
Q1 24	+22.0%	-2.4%
Q2 24	+17.9%	+1.5%
Q3 24	-30.1%	+7.9%
Q4 24	+3.3%	-9.9%
Q1 25	+24.0%	-15.2%
Q2 25	+70.5%	-7.3%
Q3 25	+89.9%	+2.2%
Q4 25	+52.0%	+48.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$2M	43.1%
Q2 23	$3M	69.6%
Q3 23	$2M	34.2%
Q4 23	$2M	24.1%
Q1 24	$2M	35.7%
Q2 24	$3M	60.1%
Q3 24	$2M	57.1%
Q4 24	$2M	24.9%
Q1 25	$2M	29.4%
Q2 25	$3M	34.9%
Q3 25	$3M	34.5%
Q4 25	$3M	20.8%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$12M	$8M
Q2 23	$13M	$7M
Q3 23	$13M	$7M
Q4 23	$11M	$7M
Q1 24	$10M	$8M
Q2 24	$11M	$9M
Q3 24	$11M	$8M
Q4 24	$9M	$9M
Q1 25	$7M	$8M
Q2 25	$9M	$9M
Q3 25	$8M	$15M
Q4 25	$7M	$21M

Revenue by Geography

Quarter	Non-US	United States
Q3 25	$2M	$6M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$45M	$83M	$128M
Q2 23	$29M	$89M	$118M
Q3 23	$56M	$70M	$125M
Q4 23	$76M	$34M	$109M
Q1 24	$91M	$8M	$99M
Q2 24	$35M	$50M	$85M
Q3 24	$27M	$47M	$74M
Q4 24	$75M	$0	$75M
Q1 25	$39M	$25M	$64M
Q2 25	$32M	$95M	$126M
Q3 25	$35M	$76M	$111M
Q4 25	$40M	$54M	$94M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	27M	-21.6%
Q2 23	28M	+4.9%
Q3 23	30M	+4.5%
Q4 23	27M	-10.5%
Q1 24	31M	+15.9%
Q2 24	31M	+0.3%
Q3 24	31M	+0.7%
Q4 24	33M	+7.4%
Q1 25	36M	+7.8%
Q2 25	30M	-17.2%
Q3 25	45M	+51.0%
Q4 25	42M	-7.2%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	—	—
FY 15	$974	39
FY 16	$6K	58
FY 17	$68K	94
FY 18	$99K	192
FY 19	$112K	191
FY 20	$60K	82
FY 21	$154K	89
FY 22	$128K	128
FY 23	$170K	132
FY 24	$192K	117
FY 25	$271K	130